From: Association of β-cell function and cognitive impairment in patients with abnormal glucose metabolism
Variables | HOMA-β | P for interaction | ||||||
---|---|---|---|---|---|---|---|---|
Q4 | Q3 | Q2 | Q1 | |||||
OR (95%CI) | OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | P | ||
Age (years old) | 0.613 | |||||||
< 60 | Ref. | 1.70 (0.85–3.39) | 0.133 | 2.02 (1.00–4.09) | 0.052 | 2.30 (1.08–4.91) | 0.032* | |
≥ 60 | Ref. | 0.86 (0.40–1.86) | 0.700 | 1.23 (0.55–2.75) | 0.613 | 2.18 (0.96–4.96) | 0.064 | |
Gender | 0.951 | |||||||
Male | Ref. | 1.23 (0.43–3.58) | 0.700 | 1.38 (0.47–4.03) | 0.550 | 2.25 (0.78–6.45) | 0.133 | |
Female | Ref. | 1.23 (0.68–2.22) | 0.497 | 1.77 (0.96–3.26) | 0.067 | 2.28 (1.18–4.40) | 0.015* | |
BMI (Kg/m2), n (%) | 0.313 | |||||||
< 25 | Ref. | 0.69 (0.21–2.30) | 0.544 | 0.83 (0.26–2.68) | 0.757 | 2.03 (0.61–6.75) | 0.246 | |
≥ 25 | Ref. | 1.59 (0.89–2.83) | 0.119 | 2.17 (1.19–3.97) | 0.012* | 2.11 (1.13–3.96) | 0.020* | |
Education level | 0.383 | |||||||
Primary education or below | Ref. | 0.34 (0.06–2.10) | 0.245 | 1.54 (0.18–13.20) | 0.695 | 0.85 (0.14–5.00) | 0.856 | |
Elementary education | Ref. | 1.64 (0.87–3.10) | 0.130 | 2.24 (1.14–4.41) | 0.020* | 2.80 (1.38–5.68) | 0.004* | |
High school education or above | Ref. | 0.89 (0.32–2.53) | 0.832 | 0.86 (0.31–2.37) | 0.775 | 1.56 (0.51–4.73) | 0.433 | |
Smoking | 0.989 | |||||||
Never | Ref. | 1.27 (0.73–2.21) | 0.396 | 1.60 (0.91–2.83) | 0.104 | 2.27 (1.24–4.13) | 0.008* | |
Former or current | Ref. | 1.39 (0.32–6.07) | 0.666 | 1.86 (0.42–8.19) | 0.412 | 2.02 (0.48–8.47) | 0.339 | |
Drinking | 0.644 | |||||||
Never | Ref. | 1.29 (0.74–2.24) | 0.365 | 1.88 (1.06–3.34) | 0.031* | 2.85 (1.54–5.28) | 0.001* | |
Former or current | Ref. | 0.73 (0.16–3.39) | 0.692 | 0.89 (0.21–3.91) | 0.882 | 0.85 (0.21–3.49) | 0.825 | |
Hypertension | 0.772 | |||||||
No | Ref. | 1.38 (0.69–2.79) | 0.363 | 1.64 (0.81–3.30) | 0.170 | 2.45 (1.17–5.15) | 0.018* | |
Yes | Ref. | 0.95 (0.44–2.04) | 0.897 | 1.38 (0.61–3.14) | 0.441 | 1.91 (0.83–4.40) | 0.131 | |
Dyslipidemia | 0.228 | |||||||
No | Ref. | 3.28 (0.89–12.09) | 0.075 | 5.00 (1.25–20.08) | 0.023* | 4.67 (1.08–20.18) | 0.039* | |
Yes | Ref. | 1.07 (0.61–1.89) | 0.804 | 1.35 (0.76–2.43) | 0.310 | 1.92 (1.05–3.51) | 0.034* | |
Heart disease | 0.938 | |||||||
No | Ref. | 1.17 (0.68–2.01) | 0.571 | 1.47 (0.84–2.55) | 0.174 | 2.00 (1.12–3.58) | 0.020* | |
Yes | Ref. | 2.54 (0.48–13.54) | 0.274 | 4.03 (0.62–26.18) | 0.144 | 9.84 (1.40–69.28) | 0.022* | |
High-Hcy | 0.420 | |||||||
No | Ref. | 1.53 (0.85–2.77) | 0.158 | 1.92 (1.04–3.54) | 0.037* | 2.20 (1.18–4.14) | 0.014* | |
Yes | Ref. | 0.76 (0.26–2.20) | 0.612 | 1.36 (0.46–4.03) | 0.576 | 3.42 (0.94–12.45) | 0.062 |